Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Additional Clofazimine on ENL Reactions in Leprosy

NCT01290744 is registered in ClinicalTrials.gov with Paul Saunderson as lead sponsor.

NCT NCT01290744
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01290744 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Additional Clofazimine on ENL Reactions in Leprosy
Lead sponsor
Paul Saunderson
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2010
Completion date
March 31, 2015
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

borderline lepromatous leprosy, lepromatous leprosy